Clinical Trial Update: Use of Transcutaneous Electrical Nerve Stimulation Device, Reletex Reliefband, With Current ERAS (Enhanced Recovery After Surgery) Protocol to Further Decrease Postoperative Nausea and Vomiting in the Bariatric Surgical Patient Within the First 24 Hours Postoperatively. [NA]

View source ↗

Summary

A clinical trial at the University of Pennsylvania is evaluating whether adding the Transcutaneous Electrical Nerve Stimulation device Reliefband to an Enhanced…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Morbid Obesity
• Postoperative Nausea and Vomiting

Drugs mentioned

• Reliefband (Transcutaneous electrical nerve stimulation device)

Snippet

Sponsor: University of Pennsylvania | Conditions: Postoperative Nausea and Vomiting, Bariatric Sleeve Gastrectomy | NA | Status: RECRUITING